Thursday, October 15, 2026
ExploreSearch
Finance Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· March 26, 2026

2026 Louisiana Energy Conference to Be Held May 26- 28 at the Four Seasons Hotel in New Orleans

View original at globenewswire.com
2026 Louisiana Energy Conference to Be Held May 26- 28 at the Four Seasons Hotel in New Orleans NEW ORLEANS, March 26, 2026 (GLOBE NEWSWIRE) -- The 26th Anniversary Louisiana Energy Conference (LEC) will be held midday Tuesday, May 26 through Thursday, May 28, 2026, at the Four Seasons Hotel, New Orleans, located at 2…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • With recent macro events impacting the energy industry, now is the perfect time to experience the Conference with about 100 companies discussing relevant topics across 30 panels

    60% confidence

  • Conference offers 1 on 1 opportunities and evening networking events at historic New Orleans locations

    60% confidence

  • Rooms may sell out quickly due to the Sail250NewOrleans event

    60% confidence

  • Attendance at the Conference is expected to qualify for continuing education credits for Louisiana and Mississippi Certified Public Accountants and Chartered Financial Analysts

    60% confidence

  • The area around the Four Seasons Hotel has undergone significant redevelopment in recent years with new hotels, more high-quality restaurants, additional attractions, and the full transformation of Caesars New Orleans

    60% confidence

  • About 100 E&P, oil field service, and future energy and other panelist firms are expected to take part in the Conference

    60% confidence

  • Registration for the first 100 investment professionals is free

    60% confidence

  • We are honored to be hosting our 26th LEC in New Orleans, where we bring together energy leaders from around the world

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com